var data={"title":"Perioperative anaphylaxis: Clinical manifestations, etiology, and management","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Perioperative anaphylaxis: Clinical manifestations, etiology, and management</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/contributors\" class=\"contributor contributor_credentials\">Jerrold H Levy, MD, FAHA, FCCM</a></dd><dd><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/contributors\" class=\"contributor contributor_credentials\">Dennis K Ledford, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/contributors\" class=\"contributor contributor_credentials\">John M Kelso, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/contributors\" class=\"contributor contributor_credentials\">Anna M Feldweg, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/contributors\" class=\"contributor contributor_credentials\">Nancy A Nussmeier, MD, FAHA</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 02, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients undergoing general anesthesia and surgery can experience complex physiologic changes, which may complicate recognition of an allergic reaction.</p><p>The prevalence, etiology, risk factors, clinical manifestations, and acute diagnosis of anaphylaxis during general anesthesia will be reviewed here. The evaluation of a patient who has experienced perioperative anaphylaxis, skin testing to the drugs that cause immunoglobulin E (IgE)-mediated reactions, and prevention of recurrent reactions, as well as the treatment of anaphylaxis from any cause, are discussed separately. (See <a href=\"topic.htm?path=perioperative-anaphylaxis-evaluation-and-prevention-of-recurrent-reactions\" class=\"medical medical_review\">&quot;Perioperative anaphylaxis: Evaluation and prevention of recurrent reactions&quot;</a> and <a href=\"topic.htm?path=anaphylaxis-emergency-treatment\" class=\"medical medical_review\">&quot;Anaphylaxis: Emergency treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">INCIDENCE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The incidence of anaphylaxis during general anesthesia is 1:10,000 to 1:20,000 [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/1-5\" class=\"abstract_t\">1-5</a>]. The wide variability in estimates of prevalence and incidence reflects the difficulties in determining the denominator (or the total number of anesthesia cases), as well as limitations in diagnosing perianesthetic anaphylaxis. Perioperative anaphylaxis occurs equally in prepubertal girls and boys, but is more common in adult women than men [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3\" class=\"abstract_t\">3</a>].</p><p class=\"headingAnchor\" id=\"H12436589\"><span class=\"h1\">MECHANISMS OF ANAPHYLAXIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Anaphylaxis is an acute, potentially lethal, multisystem syndrome almost always resulting from the sudden release of mast cell- and basophil-derived mediators into the circulation [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/6-10\" class=\"abstract_t\">6-10</a>]. (See <a href=\"topic.htm?path=pathophysiology-of-anaphylaxis\" class=\"medical medical_review\">&quot;Pathophysiology of anaphylaxis&quot;</a>.)</p><p>In this review (and increasingly in the literature), the term &quot;anaphylaxis&quot; applies to all of the following mechanisms of acute reactions (<a href=\"image.htm?imageKey=ALLRG%2F57346\" class=\"graphic graphic_table graphicRef57346 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/11\" class=\"abstract_t\">11</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immunoglobulin E (IgE)-dependent mechanisms, which account for approximately 60 percent of perioperative anaphylaxis [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/12\" class=\"abstract_t\">12</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Non-IgE-dependent immunologic mechanisms (formerly called anaphylactoid); included in this category are reactions mediated by immunoglobulin G (IgG) or immunoglobulin M (IgM) antibodies or by antigen:antibody complexes and complement.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nonimmunologic mechanisms (formerly called anaphylactoid) involving direct release of histamine and other mediators from mast cells and basophils [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/13-17\" class=\"abstract_t\">13-17</a>].</p><p/><p>The various mechanisms leading to activation of mast cells and basophils are increasingly grouped together under the term &quot;anaphylaxis&quot; because the initial management of these reactions is the same, regardless of the trigger or mechanism involved, and the clinical severity of the reactions may be similar [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/6,7\" class=\"abstract_t\">6,7</a>]. In addition, several of the agents that are commonly implicated in perioperative anaphylaxis, such as neuromuscular-blocking agents (NMBAs), are capable of causing reactions through more than one mechanism (<a href=\"image.htm?imageKey=ALLRG%2F60805\" class=\"graphic graphic_table graphicRef60805 \">table 2</a>).</p><p>Despite the similarities, there are important differences in the evaluation, prevention, and prognosis of the various types of reactions (<a href=\"image.htm?imageKey=ALLRG%2F57346\" class=\"graphic graphic_table graphicRef57346 \">table 1</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immediate-type skin testing methods (ie, prick-puncture and intradermal techniques) are only useful in evaluating IgE-mediated reactions.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The severity of IgE-mediated reactions may increase with subsequent administration of the causal agent, while the severity of repeat reactions arising from other mechanisms usually remains similar.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The severity of anaphylaxis associated with specific IgE to the culprit agent is often more severe than anaphylaxis in which specific IgE cannot be identified [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3,18\" class=\"abstract_t\">3,18</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Some IgE-mediated reactions are amenable to desensitization techniques if retreatment is required.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Reactions to radiocontrast media can be reduced in frequency or intensity by use of iso-osmolar contrast and pretreatment with antihistamines and glucocorticoids. (See <a href=\"topic.htm?path=immediate-hypersensitivity-reactions-to-radiocontrast-media-prevention-of-recurrent-reactions#H2\" class=\"medical medical_review\">&quot;Immediate hypersensitivity reactions to radiocontrast media: Prevention of recurrent reactions&quot;, section on 'Preventative measures'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">ETIOLOGIES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common identifiable causes of perioperative anaphylaxis are antibiotics, blood products, <a href=\"topic.htm?path=chlorhexidine-gluconate-drug-information\" class=\"drug drug_general\">chlorhexidine</a>, latex, and neuromuscular-blocking agents (NMBAs). However, there is a much longer list of agents that are implicated less commonly and include hypnotic induction agents, opioids, and colloids. In a significant number of cases, no specific trigger can be identified.</p><p>The best data about perioperative anaphylaxis are derived from a series of multicenter French surveys, which began in the mid-1990s and have continued to the present [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3,19-21\" class=\"abstract_t\">3,19-21</a>]. The causes of perioperative anaphylaxis can be divided into two groups (ie, more common and less common).</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">More common</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Among cases in which a trigger could be identified, the more common causes were [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/2,3,21-24\" class=\"abstract_t\">2,3,21-24</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antibiotics, especially penicillins and cephalosporins (most common cause in several American and some European studies)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>NMBAs (most common cause in many European studies)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Latex</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=chlorhexidine-gluconate-drug-information\" class=\"drug drug_general\">Chlorhexidine</a></p><p/><p>These same medications have been implicated in studies around the world, although the rank order may differ. Specifically, antibiotics appear to be the most common cause of perioperative anaphylaxis in the United States, while NMBAs are the leading cause in most European studies [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/21,25,26\" class=\"abstract_t\">21,25,26</a>].</p><p class=\"headingAnchor\" id=\"H1262939\"><span class=\"h3\">Antibiotics</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Antibiotics, administered before, during, or immediately after anesthesia, were responsible for 12 to 15 percent of identifiable triggers in the French studies [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3,22\" class=\"abstract_t\">3,22</a>]. In an American series, antibiotics accounted for 50 percent of immunoglobulin E (IgE)-mediated reactions [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/26,27\" class=\"abstract_t\">26,27</a>]. A German series of 107 patients reported 24 of the 53 identified culprit drugs to be antibiotics [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/18\" class=\"abstract_t\">18</a>].</p><p>Beta-lactam antibiotics (specifically penicillins and cephalosporins), which cause IgE-mediated anaphylaxis and <a href=\"topic.htm?path=vancomycin-drug-information\" class=\"drug drug_general\">vancomycin</a>, which usually causes reactions due to direct histamine release from mast cells, are the most common offenders [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/2,22,28-30\" class=\"abstract_t\">2,22,28-30</a>]. Quinolones are infrequently but increasingly incriminated. Hypersensitivity reactions to these agents are reviewed elsewhere. (See <a href=\"topic.htm?path=penicillin-allergy-immediate-reactions\" class=\"medical medical_review\">&quot;Penicillin allergy: Immediate reactions&quot;</a> and <a href=\"topic.htm?path=cephalosporin-allergy-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Cephalosporin allergy: Clinical manifestations and diagnosis&quot;</a> and <a href=\"topic.htm?path=vancomycin-hypersensitivity\" class=\"medical medical_review\">&quot;Vancomycin hypersensitivity&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H315537455\"><span class=\"h3\">Neuromuscular-blocking agents</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Fifty to 70 percent of anaphylaxis cases related to anesthesia were due to neuromuscular-blocking agents (NMBAs, also called muscle relaxants), making these agents the most common identifiable trigger in the French surveys [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/2,3,21,22,31\" class=\"abstract_t\">2,3,21,22,31</a>]. NMBAs can cause anaphylaxis through both IgE-mediated and nonimmunologic direct mast cell activation (<a href=\"image.htm?imageKey=ALLRG%2F60805\" class=\"graphic graphic_table graphicRef60805 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/17,32-34\" class=\"abstract_t\">17,32-34</a>]. Commonly implicated agents include <a href=\"topic.htm?path=rocuronium-drug-information\" class=\"drug drug_general\">rocuronium</a>, <a href=\"topic.htm?path=succinylcholine-suxamethonium-drug-information\" class=\"drug drug_general\">succinylcholine</a> (also known as suxamethonium), <a href=\"topic.htm?path=atracurium-drug-information\" class=\"drug drug_general\">atracurium</a>, <a href=\"topic.htm?path=pancuronium-drug-information\" class=\"drug drug_general\">pancuronium</a>, tubocurarine (no longer available in the United States and Canada but used elsewhere), and <a href=\"topic.htm?path=vecuronium-drug-information\" class=\"drug drug_general\">vecuronium</a>, although this list may largely reflect the frequency with which these agents are used [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/2,22\" class=\"abstract_t\">2,22</a>].</p><p>Allergy to NMBAs is more common in women than men, with three of four reactions occurring in females [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3,31\" class=\"abstract_t\">3,31</a>]. IgE sensitization is believed due to cross-reactive tertiary or quaternary ammonium groups found in both NMBAs and a variety of topical cosmetics and personal products, as well as certain over-the-counter cough remedies (ie, pholcodine, commonly used in France, Norway, and other European countries) [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/35-38\" class=\"abstract_t\">35-38</a>]. These ammonium groups are highly immunoreactive, multivalent epitopes, which can induce specific IgE antibodies. Sensitization through exposure to nonmedication agents may explain why allergic reactions to NMBAs can occasionally occur upon initial exposure.</p><p>There may be a specific receptor on mast cells activated by NMBAs as well as other drugs, such as fluoroquinolones [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/16\" class=\"abstract_t\">16</a>]. This receptor is designated MRGPRX2 and has the capability of binding to a variety of ligands, which could activate mast cells with a specific, immune-like response. In addition to NMBAs, these activators include substance P and peptidergic drugs, such as <a href=\"topic.htm?path=icatibant-drug-information\" class=\"drug drug_general\">icatibant</a>, used to treat hereditary angioedema by blocking the bradykinin receptor. A specific inhibitor of MRGPRX2 in animal models has blocked IgE-independent anaphylaxis.</p><p>Reactions resulting from IgE-mediated allergy are less common, although usually more severe, than reactions due to direct mast cell activation. Histamine release may be more prominent with certain NMBAs, such as tubocurarine, <a href=\"topic.htm?path=mivacurium-drug-information\" class=\"drug drug_general\">mivacurium</a>, <a href=\"topic.htm?path=atracurium-drug-information\" class=\"drug drug_general\">atracurium</a>, and rapacuronium. Rapacuronium was withdrawn from the United States market, because it was implicated in high rates of severe bronchospasm (without other symptoms) [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/39\" class=\"abstract_t\">39</a>].</p><p>It is possible that the prevalence of sensitization to NMBAs is overestimated to some degree. The high rate of reactions attributed to NMBAs in some studies may be based upon skin testing results, and these drugs can cause nonspecific mast cell release, causing false-positives skin test results [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/38\" class=\"abstract_t\">38</a>]. Skin testing to NMBAs and cross-reactivity among these drugs are discussed separately. (See <a href=\"topic.htm?path=perioperative-anaphylaxis-evaluation-and-prevention-of-recurrent-reactions#H12\" class=\"medical medical_review\">&quot;Perioperative anaphylaxis: Evaluation and prevention of recurrent reactions&quot;, section on 'Neuromuscular-blocking agents'</a>.)</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Latex</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Natural rubber latex historically has accounted for approximately 20 percent of perioperative anaphylaxis cases [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/2,3,22\" class=\"abstract_t\">2,3,22</a>]. The percentage is declining, as the exposure to latex has been reduced in most surgical suites in the United States and other countries.</p><p>Anaphylaxis to latex is an IgE-mediated process resulting from the formation of specific IgE against proteins from natural rubber latex. There are a variety of potential sources of latex in surgical and procedural settings (<a href=\"image.htm?imageKey=ALLRG%2F51530\" class=\"graphic graphic_table graphicRef51530 \">table 3</a>). The most common sources of significant latex exposure in the perioperative setting are flexible items from which latex allergen is easily eluted and that have prolonged contact with skin or mucosal surfaces, such as:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gloves (sterile and exam)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Drains (Penrose and others)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Catheters (indwelling, straight, and condom)</p><p/><p>Hard rubber items, such as straps, tubing, and blood pressure cuffs, elute little or no latex protein and do not contact patient tissues to the same extent as surgical gloves, catheters, and drains. Items that are now usually latex-free include bags used in manual ventilation, leg straps for catheter bags, bandages and adhesive pads, tape, electrode pads, endotracheal tubes, infusion sets and ports, and suction catheters.</p><p>Reactions to latex tend to occur later in surgical procedures (eg, 30 minutes or more after the start of the intervention). Symptoms may develop after visceral surfaces have been handled or manipulated by clinicians wearing latex gloves.</p><p>Latex allergy is more likely in subjects with repeated exposure to latex gloves or catheters from prior surgeries or from occupational use, especially children with spina bifida and health care workers [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/40\" class=\"abstract_t\">40</a>]. Sensitization to latex can occur as a result of contact with nonmedical sources of latex as well (eg, condoms, balloons, household gloves), and reactions are not limited to patients in high-risk groups. Latex allergy is reviewed in detail separately. (See <a href=\"topic.htm?path=latex-allergy-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Latex allergy: Epidemiology, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=latex-allergy-management\" class=\"medical medical_review\">&quot;Latex allergy: Management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H118732057\"><span class=\"h3\">Chlorhexidine</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=chlorhexidine-gluconate-drug-information\" class=\"drug drug_general\">Chlorhexidine</a> is a topical antiseptic and surgical scrub that is increasingly implicated in perioperative anaphylaxis [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/23,41-49\" class=\"abstract_t\">23,41-49</a>]. Reported culprit products include antiseptic solutions applied to surgical fields (especially mucosal surfaces) and urethral lubricants. Some central venous catheter tips are impregnated with chlorhexidine. This compound is found in nonmedical settings in toothpastes, antiseptic mouthwashes, bathing solutions, and lozenges. Patients may become sensitized through exposure to such products.</p><p class=\"headingAnchor\" id=\"H597059\"><span class=\"h2\">Less common</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the French studies mentioned previously, the following groups of agents were implicated in less than 10 to 15 percent<strong> </strong>of reactions [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3\" class=\"abstract_t\">3</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Colloids and plasma volume expanders</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypnotic induction agents</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Opioids</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other agents</p><p/><p class=\"headingAnchor\" id=\"H1019505258\"><span class=\"h3\">Colloids and plasma expanders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Colloids and plasma expanders, such as dextran or <a href=\"topic.htm?path=hetastarch-hydroxyethyl-starch-450-0-7-hespan-hextend-drug-information\" class=\"drug drug_general\">hetastarch</a> (hydroxyethyl starch [HES]), accounted for approximately 3 percent of identifiable causes of perioperative anaphylaxis [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/2,22\" class=\"abstract_t\">2,22</a>]. These agents are capable of causing both IgE-mediated and non-IgE-mediated immunologic reactions. Reported rates of anaphylaxis were &lt;0.1 percent of administrations for each of several preparations [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/31,50,51\" class=\"abstract_t\">31,50,51</a>]. Hetastarch is used in major surgeries expected to cause significant fluid shifts (eg, trauma). Dextran is less commonly used as a volume expander, but its antiplatelet effects make it useful as an adjunct to some vascular procedures.</p><p>Albumin has also been implicated in rare perioperative anaphylactic reactions, although the mechanisms have not been explored [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/52,53\" class=\"abstract_t\">52,53</a>]. In addition, gelatin in the plasma expanders polygeline (eg, Haemaccel) and succinylated gelatins (eg, Gelofusine) has caused IgE-mediated anaphylactic reactions [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/54,55\" class=\"abstract_t\">54,55</a>]. Gelatin-containing plasma expanders are not in use in the United States, although they are used in other countries.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Hypnotic induction agents</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypnotic induction agents account for approximately 2 percent of perioperative anaphylaxis cases [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3\" class=\"abstract_t\">3</a>]. There are two types of induction agents: barbiturates (eg, thiopental, <a href=\"topic.htm?path=methohexital-drug-information\" class=\"drug drug_general\">methohexital</a>) and nonbarbiturates (eg, <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a>, <a href=\"topic.htm?path=etomidate-drug-information\" class=\"drug drug_general\">etomidate</a>, <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a>, benzodiazepines). (See <a href=\"topic.htm?path=general-anesthesia-intravenous-induction-agents\" class=\"medical medical_review\">&quot;General anesthesia: Intravenous induction agents&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Barbiturates</strong> &ndash; Intravenous barbiturates were previously widely used in anesthesia, and as a class, they account for most reactions to induction agents. Women are affected three times more often than men [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/22,32\" class=\"abstract_t\">22,32</a>]. Most reactions caused by barbiturate induction agents are IgE-mediated, although direct mast cell activation has also been described (<a href=\"image.htm?imageKey=ALLRG%2F60805\" class=\"graphic graphic_table graphicRef60805 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/14,31,56,57\" class=\"abstract_t\">14,31,56,57</a>]. There is some immunologic cross-reactivity among the barbiturates [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/56\" class=\"abstract_t\">56</a>]. Thiopental and thiamylal are no longer available in the United States but are still used in some other countries.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Nonbarbiturates</strong> &ndash; Anaphylaxis to nonbarbiturate induction agents is very rare. <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">Propofol</a> is a nonbarbiturate induction agent that was initially solubilized in Cremophor (polyethoxylated castor oil), a vehicle that causes non-IgE-mediated anaphylactic reactions [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/58\" class=\"abstract_t\">58</a>]. Subsequently, the vehicle for propofol was changed to a soybean oil emulsion with egg phosphatide and glycerol [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/58-60\" class=\"abstract_t\">58-60</a>]. Allergic reactions to these newer preparations appear to be even rarer. Although allergies to egg or soybean are listed in the product information as contraindications to use [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/61\" class=\"abstract_t\">61</a>], the vast majority of egg- and soy-allergic subjects tolerate propofol [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/62,63\" class=\"abstract_t\">62,63</a>].</p><p/><p class=\"bulletIndent1\">Benzodiazepines are also nonbarbiturate induction agents. Hypotension following intravenous administration is a known adverse effect of these agents, although anaphylactic reactions are very rare [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/64\" class=\"abstract_t\">64</a>]. Benzodiazepines may be capable of activating mast cells in vitro [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/14\" class=\"abstract_t\">14</a>]. Skin testing with benzodiazepines has been reported [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/65\" class=\"abstract_t\">65</a>], although the significance of a positive wheal-and-flare skin reaction is unknown. Cross-reactivity between <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> and benzodiazepines has not been reported and is unlikely.</p><p/><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Opioids</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Opioids used in <span class=\"nowrap\">anesthesia/analgesia</span> are a common cause of flushing and urticaria following intravenous administration, although opioids rarely cause life-threatening reactions. Typically, opioids cause limited cutaneous symptoms that are non-IgE-mediated. <a href=\"topic.htm?path=morphine-drug-information\" class=\"drug drug_general\">Morphine</a> or <a href=\"topic.htm?path=meperidine-pethidine-drug-information\" class=\"drug drug_general\">meperidine</a> can cause degranulation of dermal mast cells and release of histamine and other mediators, leading to flushing and urticaria, although rarely angioedema, bronchospasm, or hypotension [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/17\" class=\"abstract_t\">17</a>].</p><p>Specific IgE to <a href=\"topic.htm?path=morphine-drug-information\" class=\"drug drug_general\">morphine</a> or <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a> has been implicated in case reports, although skin testing with opioids requires specific dilutions, because direct mast cell activation, particularly by morphine and <a href=\"topic.htm?path=codeine-drug-information\" class=\"drug drug_general\">codeine</a>, can result in false-positive results [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/66,67\" class=\"abstract_t\">66,67</a>]. Fentanyl and <a href=\"topic.htm?path=sufentanil-drug-information\" class=\"drug drug_general\">sufentanil</a> are less likely to directly activate mast cells but may cause mast cell degranulation through specific, potent mu receptors. However, testing with fentanyl and sufentanil may cause false-positive results due to direct vasodilation [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/68\" class=\"abstract_t\">68</a>]. Skin testing to opioids is reviewed separately. (See <a href=\"topic.htm?path=perioperative-anaphylaxis-evaluation-and-prevention-of-recurrent-reactions#H25\" class=\"medical medical_review\">&quot;Perioperative anaphylaxis: Evaluation and prevention of recurrent reactions&quot;, section on 'Opioids'</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Other agents</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A variety of other medications and agents have been implicated in anaphylaxis or reactions resembling anaphylaxis [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/13\" class=\"abstract_t\">13</a>]. Collectively, these other agents account for less than 5 percent of all episodes of perioperative anaphylaxis [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3\" class=\"abstract_t\">3</a>]. Skin testing protocols for some of these agents are discussed separately (see <a href=\"topic.htm?path=perioperative-anaphylaxis-evaluation-and-prevention-of-recurrent-reactions#H11\" class=\"medical medical_review\">&quot;Perioperative anaphylaxis: Evaluation and prevention of recurrent reactions&quot;, section on 'Specific agents'</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Radiocontrast agents (see <a href=\"topic.htm?path=immediate-hypersensitivity-reactions-to-radiocontrast-media-clinical-manifestations-diagnosis-and-treatment\" class=\"medical medical_review\">&quot;Immediate hypersensitivity reactions to radiocontrast media: Clinical manifestations, diagnosis, and treatment&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Blood transfusion (see <a href=\"topic.htm?path=immunologic-transfusion-reactions\" class=\"medical medical_review\">&quot;Immunologic transfusion reactions&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Metabisulfites and bisulfites used as preservatives in medications [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/69-73\" class=\"abstract_t\">69-73</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nonsteroidal anti-inflammatory drugs (NSAIDs) (see <a href=\"topic.htm?path=nsaids-including-aspirin-allergic-and-pseudoallergic-reactions\" class=\"medical medical_review\">&quot;NSAIDs (including aspirin): Allergic and pseudoallergic reactions&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Povidone in the topical antiseptic povidone-iodine [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/74,75\" class=\"abstract_t\">74,75</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=bacitracin-drug-information\" class=\"drug drug_general\">Bacitracin</a> used in irrigation solutions [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/76-80\" class=\"abstract_t\">76-80</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The sterilization agents ethylene oxide and ortho-phthalaldehyde (Cidex OPA) [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/81-86\" class=\"abstract_t\">81-86</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Streptokinase or urokinase [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/87,88\" class=\"abstract_t\">87,88</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=isosulfan-blue-dye-drug-information\" class=\"drug drug_general\">Isosulfan blue dye</a> (used in sentinel node biopsies) and other vital dyes [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/89-92\" class=\"abstract_t\">89-92</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chymopapain (used in herniated disc surgery) and papain [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/93-96\" class=\"abstract_t\">93-96</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Insulin [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/97,98\" class=\"abstract_t\">97,98</a>] (see <a href=\"topic.htm?path=hypersensitivity-reactions-to-insulins\" class=\"medical medical_review\">&quot;Hypersensitivity reactions to insulins&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Local anesthetics [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/99,100\" class=\"abstract_t\">99,100</a>] (see <a href=\"topic.htm?path=allergic-reactions-to-local-anesthetics\" class=\"medical medical_review\">&quot;Allergic reactions to local anesthetics&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Heparin and other anticoagulants [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/101-103\" class=\"abstract_t\">101-103</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Galactose-alpha-1,3-galactose (alpha-gal) in bovine and porcine valves or in bovine or porcine heparin or gelatin [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/104,105\" class=\"abstract_t\">104,105</a>] (see <a href=\"topic.htm?path=allergy-to-meats\" class=\"medical medical_review\">&quot;Allergy to meats&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gelatin-containing surgical sponges and topical bovine thrombin hemostatic agents [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/106,107\" class=\"abstract_t\">106,107</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Protamine, used to reverse heparinization [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/108,109\" class=\"abstract_t\">108,109</a>] (see <a href=\"topic.htm?path=hypersensitivity-reactions-to-insulins#H25137720\" class=\"medical medical_review\">&quot;Hypersensitivity reactions to insulins&quot;, section on 'Protamine'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Aprotinin, administered either intravenously or as a component of biologic sealants [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3,15,110,111\" class=\"abstract_t\">3,15,110,111</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=hyaluronidase-drug-information\" class=\"drug drug_general\">Hyaluronidase</a>, used to enhance the diffusion of other drugs and agents [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/112-116\" class=\"abstract_t\">112-116</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=sugammadex-drug-information\" class=\"drug drug_general\">Sugammadex</a>, used to reverse muscle relaxants [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/117-120\" class=\"abstract_t\">117-120</a>]</p><p/><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Risk factors for perioperative anaphylaxis include female sex (for certain medications), mast cell disorders, history of anaphylaxis, allergic drug reactions, or other allergic conditions (such as asthma, eczema, or hay fever), and multiple past surgeries or procedures (especially for latex and ethylene oxide). However, even in patients at increased risk, perioperative anaphylaxis is an uncommon event.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with asthma are at greater risk for fatal anaphylaxis from a variety of causes and may be at higher risk for perioperative anaphylaxis, although data are mixed [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3,121,122\" class=\"abstract_t\">3,121,122</a>]. In a series of 106 patients, a history of asthma was not associated with an increased risk of intraoperative anaphylaxis or of developing bronchospasm during intraoperative anaphylaxis [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/123\" class=\"abstract_t\">123</a>]. The only factor that was associated with increased risk of bronchospasm was exposure to neuromuscular-blocking agents (NMBAs). Bronchospasm occurred with other symptoms of anaphylaxis in 30 percent of cases and as an isolated manifestation of a reaction in 3 percent.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Women are at higher risk than men for reactions to NMBAs and hypnotic induction agents, although reactions are equal for males and females before adolescence.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Previous medication reactions nonspecifically increase the possibility of future adverse medication reactions, and multiple previous drug reactions pose a proportionately greater risk.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with multiple past surgeries or other procedures may be at increased risk for latex allergy and reactions to NMBAs. (See <a href=\"topic.htm?path=latex-allergy-epidemiology-clinical-manifestations-and-diagnosis#H17\" class=\"medical medical_review\">&quot;Latex allergy: Epidemiology, clinical manifestations, and diagnosis&quot;, section on 'Diagnosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with mast cell disorders, including idiopathic mast cell activation syndrome, monoclonal mast cell activation disorder, and systemic mastocytosis, are at increased risk for clinically significant mast cell-mediator release from a variety of stimuli, including the administration of medications that cause nonspecific mast cell activation and physiologic events during surgery (eg, handling of the bowel, extremes of temperature) [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/124\" class=\"abstract_t\">124</a>]. Thus, these patients require specific precautionary management prior to procedures or surgery. (See <a href=\"topic.htm?path=systemic-mastocytosis-management-and-prognosis#H6\" class=\"medical medical_review\">&quot;Systemic mastocytosis: Management and prognosis&quot;, section on 'Preparation for medical and surgical procedures'</a> and <a href=\"topic.htm?path=mast-cell-disorders-an-overview#H4290513\" class=\"medical medical_review\">&quot;Mast cell disorders: An overview&quot;, section on 'Mast cell physiology'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">CLINICAL MANIFESTATIONS AND DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of perioperative anaphylaxis is clinical and based upon the presence of characteristic signs and symptoms that begin suddenly and progress rapidly in most cases. There is no definitive test to prove or disprove anaphylaxis.</p><p class=\"headingAnchor\" id=\"H3441557936\"><span class=\"h2\">Characteristic signs and symptoms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are important differences in the presentation of anaphylaxis in an intubated and sedated patient compared with an ambulatory patient (<a href=\"image.htm?imageKey=ALLRG%2F51806\" class=\"graphic graphic_table graphicRef51806 \">table 4</a>) [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/125\" class=\"abstract_t\">125</a>]. In the perioperative setting, early or mild symptoms, such as itching or shortness of breath, may go unnoticed if the patient cannot communicate. Skin symptoms may be present but may not be noticed if the skin is draped or covered. Therefore, anaphylaxis is more likely to present as sudden changes in cardiovascular or respiratory parameters [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/92\" class=\"abstract_t\">92</a>]. Cardiovascular collapse, which can present with signs ranging from hypotension to cardiac arrest, is the first detected manifestation in up to 50 percent of cases [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypotension is common during anesthetic induction (especially with <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a>). Recognizing hypotension that is part of anaphylaxis can also be complicated by the effects of positive pressure ventilation, surgical manipulation, and sympathectomy associated with <span class=\"nowrap\">spinal/epidural</span> anesthesia. Additional causes of hypotension are discussed below. (See <a href=\"#H22\" class=\"local\">'Other causes of hypotension/shock'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bronchospasm may present as a sudden increase in the ventilatory pressure required to inflate the lungs, an upsloping pattern in the end-tidal carbon dioxide waveform or a decrease in arterial oxygen saturation.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rapidly developing laryngeal edema may present as difficulty with intubation or as postextubation stridor.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tachycardia is a classic cardiovascular sign of anaphylaxis, although bradycardia occasionally develops later in the reaction if the patient becomes hypoxemic or develops heart block [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/126\" class=\"abstract_t\">126</a>].</p><p/><p>As a result of these factors, anaphylaxis may be recognized only when dramatic respiratory and hemodynamic changes develop.</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Timing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Anaphylaxis due to an immunoglobulin E (IgE)-mediated reaction usually develops within a few minutes to approximately 20 minutes following intravenous administration of the causal agent. Symptoms may manifest later if the trigger was administered orally, intramuscularly, or through contact with skin or tissues (latex). Timing of the reaction with respect to the onset of anesthesia may provide additional clues to the underlying cause:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Allergic reactions occurring during the first 30 minutes of anesthesia are more likely due to antibiotics, neuromuscular-blocking agents (NMBAs), or hypnotic induction agents, because these agents are given at the start of the procedure.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anaphylaxis presenting after the first 30 minutes of anesthetic induction are more likely due to agents that are used during or at the conclusion of a surgical procedure, such as latex, blood products, colloid volume expanders, vital dyes, or protamine.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=sugammadex-drug-information\" class=\"drug drug_general\">Sugammadex</a>, a polysaccharide compound, is increasingly reported as a cause of anaphylaxis (approximately 1:33,000) at the conclusion of anesthesia, as this agent is used to reverse muscle paralysis. Sugammadex was US Food and Drug Administration (FDA)-approved in December 2015 and likely there will be increased use in the United States [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/117,118\" class=\"abstract_t\">117,118</a>].</p><p/><p>Reactions may also occur after sudden shifts in blood or other fluids, such as removal of a tourniquet, unclamping of blood vessels, or after uterine manipulation followed by administration of <a href=\"topic.htm?path=oxytocin-drug-information\" class=\"drug drug_general\">oxytocin</a> [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/2,127,128\" class=\"abstract_t\">2,127,128</a>].</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Severity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Perioperative anaphylaxis tends to be severe and has a higher mortality rate than anaphylaxis occurring in other settings. Estimates of mortality due to perioperative anaphylaxis range from 1.4 to 6 percent, with another 2 percent of patients surviving with anoxic cerebral injury [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/12,122,129\" class=\"abstract_t\">12,122,129</a>]. In contrast, fatal anaphylaxis from all causes has been estimated to be 0.7 to 2 percent of cases. The heightened severity of perioperative anaphylaxis may be attributable to the intravenous route of drug administration <span class=\"nowrap\">and/or</span> the factors that impair early recognition of reactions. Another possibility is that individuals receiving anesthesia may be more vulnerable to physiologic perturbations, especially following <span class=\"nowrap\">spinal/epidural</span> anesthesia, which may cause a sympathectomy. The concomitant stresses of surgery or illness may also contribute.</p><p>IgE-mediated anaphylaxis is generally more severe than non-IgE-mediated anaphylaxis [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3\" class=\"abstract_t\">3</a>], although both types can be fatal. A review of fatal anaphylaxis from all causes is presented elsewhere. (See <a href=\"topic.htm?path=fatal-anaphylaxis\" class=\"medical medical_review\">&quot;Fatal anaphylaxis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3949944398\"><span class=\"h1\">MANAGEMENT</span></p><p class=\"headingAnchor\" id=\"H2199109078\"><span class=\"h2\">Initial management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The treatment of anaphylaxis during anesthesia is based upon prompt administration of <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> and fluid resuscitation (<a href=\"image.htm?imageKey=ALLRG%2F107933\" class=\"graphic graphic_table graphicRef107933 \">table 5</a>).<em> </em>The <span class=\"nowrap\">perioperative/intensive</span> care unit setting is one of the few places that intravenous bolus epinephrine is used regularly in initial management, outside of advanced cardiac life support algorithms. For acute shock and cardiopulmonary dysfunction, it is essential to use intravenous treatment agents, carefully titrated to specific effects. In most other settings, clinicians should use intramuscular epinephrine for anaphylaxis.</p><p>A detailed discussion of anaphylaxis management in other settings is found separately. (See <a href=\"topic.htm?path=anaphylaxis-emergency-treatment\" class=\"medical medical_review\">&quot;Anaphylaxis: Emergency treatment&quot;</a>.)</p><p>Subsequent allergy evaluation should take place after the patient has recovered fully. This evaluation is reviewed separately. (See <a href=\"topic.htm?path=perioperative-anaphylaxis-evaluation-and-prevention-of-recurrent-reactions\" class=\"medical medical_review\">&quot;Perioperative anaphylaxis: Evaluation and prevention of recurrent reactions&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Laboratory tests at the time of the reaction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Blood collected at the time of the reaction (or shortly after) may reveal elevations in tryptase or histamine, which are mediators released by mast cells and basophils. The release of these mediators can help distinguish anaphylaxis from other perioperative events, such as cardiogenic shock [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/130,131\" class=\"abstract_t\">130,131</a>]. Elevations in serum tryptase are most often detected in cases of anaphylaxis that involve hypotension.</p><p>Mediator release occurs transiently following significant mast cell activation. Elevations of mast cell mediators in the blood can help to distinguish anaphylaxis from other disorders that present similarly, although normal levels do not exclude anaphylaxis. Serum tryptase &gt;11.4 <span class=\"nowrap\">ng/mL</span> is considered elevated. However, a patient may have a much lower tryptase value at baseline, in which case an increase in serum total tryptase of 20 percent + 2 <span class=\"nowrap\">ng/mL</span> is accepted as evidence of mast cell activation, even if the maximum increase is within the normal range. The equation 1.2 x baseline tryptase + 2 <span class=\"nowrap\">ng/mL</span> is used to calculate the level indicative of mast cell activation [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/132\" class=\"abstract_t\">132</a>]. For example, if a patient's baseline tryptase is 2 <span class=\"nowrap\">ng/mL,</span> then a level of 7 <span class=\"nowrap\">ng/mL</span> drawn shortly after a perioperative reaction is consistent with anaphylaxis. In most cases, the patient's baseline serum tryptase is not known, but it can be obtained by repeating the serum tryptase several days after the reaction, as tryptase is rapidly cleared from the circulation. Tryptase was elevated in 68 percent of immunoglobulin E (IgE)-mediated reactions and 4 percent of non-IgE-mediated reactions in the largest French study [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3\" class=\"abstract_t\">3</a>]. The interpretation of laboratory tests in patients with anaphylaxis is discussed in more detail elsewhere. (See <a href=\"topic.htm?path=laboratory-tests-to-support-the-clinical-diagnosis-of-anaphylaxis\" class=\"medical medical_review\">&quot;Laboratory tests to support the clinical diagnosis of anaphylaxis&quot;</a>.)</p><p>Serum tryptase has a half-life of approximately two hours. Blood for serum tryptase should be collected as soon as possible after the onset of symptoms [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/133\" class=\"abstract_t\">133</a>]. Thirty minutes to three hours after the onset of symptoms is optimal, although increases may be detectable longer following massive mediator release. Blood for serum tryptase should be collected in a red top tube, and a minimum of 1 mL is recommended.</p><p>Serum that was collected at the time of the reaction for other reasons can sometimes be retrieved at a later time and assayed. Tryptase is stable in frozen serum for up to one year. Levels of tryptase can increase dramatically after death due to nonspecific mediator release during cell death. For postmortem samples, blood should be collected from the femoral artery or vein and not the heart. (See <a href=\"topic.htm?path=laboratory-tests-to-support-the-clinical-diagnosis-of-anaphylaxis#H11\" class=\"medical medical_review\">&quot;Laboratory tests to support the clinical diagnosis of anaphylaxis&quot;, section on 'Fatal anaphylaxis'</a>.)</p><p>Assays of other mast cell and basophil products, such as serum and urinary histamine, histamine metabolites, and prostaglandins, are of limited clinical value. (See <a href=\"topic.htm?path=laboratory-tests-to-support-the-clinical-diagnosis-of-anaphylaxis\" class=\"medical medical_review\">&quot;Laboratory tests to support the clinical diagnosis of anaphylaxis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4054093197\"><span class=\"h2\">Decisions regarding proceeding with surgery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The decision to proceed with surgery following anaphylaxis should be individualized depending on the severity of the reaction, cardiopulmonary stability, and the urgency of the procedural intervention. Ultimately, the clinicians involved must use clinical judgement to determine the most sensible course of action. In one retrospective analysis, proceeding with surgery was safe after grade 1 or 2 anaphylactic reactions (limited to cutaneous signs <span class=\"nowrap\">and/or</span> vital sign changes that are not life-threatening). After grade 3 reactions (profound hypotension or severe bronchospasm), the risk of adverse events attributable to the reaction was higher but did not differ in cases where surgery was continued or abandoned [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/134\" class=\"abstract_t\">134</a>]. Surgical procedures were frequently abandoned after grade 4 reactions (associated with cardiac arrest <span class=\"nowrap\">and/or</span> inability to ventilate) in this study, although there was no evidence of further harm when clinicians decided to proceed with emergency or partially completed major surgery.</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of an allergic or anaphylactic reaction during or following general anesthesia includes a broad list of reactions and physiologic events [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/28,135,136\" class=\"abstract_t\">28,135,136</a>]. Tryptase levels should be normal in <strong>all</strong> of these other disorders:</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Other causes of respiratory or airway symptoms</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute asthmatic reaction (see <a href=\"topic.htm?path=anesthesia-for-adult-patients-with-asthma#H1234674393\" class=\"medical medical_review\">&quot;Anesthesia for adult patients with asthma&quot;, section on 'Intraoperative bronchospasm'</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Aspiration</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Endotracheal tube malposition</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malignant hyperthermia (<a href=\"topic.htm?path=succinylcholine-suxamethonium-drug-information\" class=\"drug drug_general\">succinylcholine</a>) (see <a href=\"topic.htm?path=malignant-hyperthermia-clinical-diagnosis-and-management-of-acute-crisis#H647216233\" class=\"medical medical_review\">&quot;Malignant hyperthermia: Clinical diagnosis and management of acute crisis&quot;, section on 'Clinical diagnosis'</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Myotonias and masseter spasm (<a href=\"topic.htm?path=succinylcholine-suxamethonium-drug-information\" class=\"drug drug_general\">succinylcholine</a>) (see <a href=\"topic.htm?path=neuromuscular-blocking-agents-nmbas-for-rapid-sequence-intubation-in-adults-outside-of-the-operating-room#H12\" class=\"medical medical_review\">&quot;Neuromuscular blocking agents (NMBAs) for rapid sequence intubation in adults outside of the operating room&quot;, section on 'Trismus'</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Postextubation stridor (see <a href=\"topic.htm?path=respiratory-problems-in-the-post-anesthesia-care-unit-pacu#H418849271\" class=\"medical medical_review\">&quot;Respiratory problems in the post-anesthesia care unit (PACU)&quot;, section on 'Upper airway obstruction'</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary edema</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary embolus (see <a href=\"topic.htm?path=clinical-presentation-evaluation-and-diagnosis-of-the-nonpregnant-adult-with-suspected-acute-pulmonary-embolism\" class=\"medical medical_review\">&quot;Clinical presentation, evaluation, and diagnosis of the nonpregnant adult with suspected acute pulmonary embolism&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tension pneumothorax (see <a href=\"topic.htm?path=imaging-of-pneumothorax\" class=\"medical medical_review\">&quot;Imaging of pneumothorax&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Transfusion-related acute lung injury (TRALI) (see <a href=\"topic.htm?path=transfusion-related-acute-lung-injury-trali#H8\" class=\"medical medical_review\">&quot;Transfusion-related acute lung injury (TRALI)&quot;, section on 'Clinical presentation'</a>)</p><p/><p>(See <a href=\"topic.htm?path=assessment-of-respiratory-distress-in-the-mechanically-ventilated-patient\" class=\"medical medical_review\">&quot;Assessment of respiratory distress in the mechanically ventilated patient&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Other causes of hypotension/shock</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Arrhythmias</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cardiac tamponade (see <a href=\"topic.htm?path=cardiac-tamponade#H9\" class=\"medical medical_review\">&quot;Cardiac tamponade&quot;, section on 'Acute cardiac tamponade'</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cardiogenic shock</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hemorrhage</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hyperkalemia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Overdose of vasoactive drugs</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Partial sympathectomy from <span class=\"nowrap\">spinal/epidural</span> anesthesia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sepsis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vasovagal reaction</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Venous air embolism (see <a href=\"topic.htm?path=air-embolism#H10\" class=\"medical medical_review\">&quot;Air embolism&quot;, section on 'Clinical features'</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malignant hyperthermia (<a href=\"topic.htm?path=succinylcholine-suxamethonium-drug-information\" class=\"drug drug_general\">succinylcholine</a>) (see <a href=\"topic.htm?path=malignant-hyperthermia-clinical-diagnosis-and-management-of-acute-crisis#H647216233\" class=\"medical medical_review\">&quot;Malignant hyperthermia: Clinical diagnosis and management of acute crisis&quot;, section on 'Clinical diagnosis'</a>)</p><p/><p class=\"headingAnchor\" id=\"H23\"><span class=\"h2\">Other causes of angioedema</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hereditary or acquired C1 inhibitor deficiency (see <a href=\"topic.htm?path=hereditary-angioedema-treatment-of-acute-attacks\" class=\"medical medical_review\">&quot;Hereditary angioedema: Treatment of acute attacks&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment with angiotensin-converting enzyme inhibitors and possibly angiotensin-receptor blockers (see <a href=\"topic.htm?path=an-overview-of-angioedema-pathogenesis-and-causes\" class=\"medical medical_review\">&quot;An overview of angioedema: Pathogenesis and causes&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H24\"><span class=\"h2\">Other causes of urticaria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cold urticaria can occasionally be mistaken for perioperative anaphylaxis or a drug reaction. Cold urticaria can usually be excluded by the negative results of an ice cube challenge, except for familial cold urticaria associated with cryopyrin dysfunction [<a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/137\" class=\"abstract_t\">137</a>]. (See <a href=\"topic.htm?path=cold-urticaria\" class=\"medical medical_review\">&quot;Cold urticaria&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H19132984\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-anaphylaxis\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Anaphylaxis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anaphylaxis is a potentially lethal reaction usually resulting from the sudden, clinically significant release of mast cell- <span class=\"nowrap\">and/or</span> basophil-derived mediators into the circulation. Both immunoglobulin E (IgE)-and non-IgE-mediated mechanisms have been implicated, and some agents may cause reactions by more than one mechanism (<a href=\"image.htm?imageKey=ALLRG%2F57346\" class=\"graphic graphic_table graphicRef57346 \">table 1</a> and <a href=\"image.htm?imageKey=ALLRG%2F60805\" class=\"graphic graphic_table graphicRef60805 \">table 2</a>). (See <a href=\"#H12436589\" class=\"local\">'Mechanisms of anaphylaxis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The more common identifiable causes of perioperative anaphylaxis are antibiotics, neuromuscular-blocking agents (NMBAs), latex, and <a href=\"topic.htm?path=chlorhexidine-gluconate-drug-information\" class=\"drug drug_general\">chlorhexidine</a>. However, there is a much longer list of agents that are implicated less commonly. (See <a href=\"#H4\" class=\"local\">'Etiologies'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Risk factors for perioperative anaphylaxis include female sex (for certain medications), other allergic conditions (eg, asthma, eczema, or hay fever), multiple past surgeries or procedures (especially for latex), and mast cell disorders. (See <a href=\"#H13\" class=\"local\">'Risk factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Perioperative anaphylaxis may exhibit cutaneous, respiratory, and cardiovascular signs and symptoms, as well as variable involvement of other organ systems, although these signs may be more difficult to recognize in sedated or anesthetized patients (<a href=\"image.htm?imageKey=ALLRG%2F51806\" class=\"graphic graphic_table graphicRef51806 \">table 4</a>). The diagnosis is clinical. One-half of cases are initially detected as sudden cardiovascular collapse. Bronchospasm may present as an increase in the ventilatory pressure required to inflate the lungs or as a decrease in arterial oxygen saturation. (See <a href=\"#H14\" class=\"local\">'Clinical manifestations and diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Perioperative anaphylaxis tends to be severe and has a higher mortality rate than anaphylaxis occurring in other settings. This is at least partly attributable to factors that impair early recognition of anaphylaxis, such as the inability of the patient to report initial symptoms and coverage of the skin with surgical drapes. The intravenous administration of triggering drugs and concomitant stresses of surgery or illness may also contribute. (See <a href=\"#H17\" class=\"local\">'Severity'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The treatment of anaphylaxis during anesthesia is based upon prompt administration of <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> and fluid resuscitation (<a href=\"image.htm?imageKey=ALLRG%2F107933\" class=\"graphic graphic_table graphicRef107933 \">table 5</a>). Intravenous epinephrine is commonly used in the operating room while the patient is monitored, and intravenous access is readily available. (See <a href=\"#H2199109078\" class=\"local\">'Initial management'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An elevated serum total tryptase, ideally obtained within three hours of a suspected reaction, is highly suggestive of anaphylaxis, although normal levels do not exclude the diagnosis. If initially increased, total tryptase should be measured again after recovery to exclude the possibility that tryptase is chronically elevated due to a mast cell disorder. (See <a href=\"#H19\" class=\"local\">'Laboratory tests at the time of the reaction'</a> above and <a href=\"#H20\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/1\" class=\"nounderline abstract_t\">Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993; 12:97.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/2\" class=\"nounderline abstract_t\">Laxenaire MC. [Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994-December 1996)]. Ann Fr Anesth Reanim 1999; 18:796.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/3\" class=\"nounderline abstract_t\">Mertes PM, Alla F, Tr&eacute;chot P, et al. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 2011; 128:366.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/4\" class=\"nounderline abstract_t\">Mertes PM, Malinovsky JM, Jouffroy L, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 2011; 21:442.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/5\" class=\"nounderline abstract_t\">Mertes PM, Volcheck GW, Garvey LH, et al. Epidemiology of perioperative anaphylaxis. Presse Med 2016; 45:758.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/6\" class=\"nounderline abstract_t\">Sampson HA, Mu&ntilde;oz-Furlong A, Bock SA, et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005; 115:584.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/7\" class=\"nounderline abstract_t\">Sampson HA, Mu&ntilde;oz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/8\" class=\"nounderline abstract_t\">Lieberman P. Mechanisms of anaphylaxis beyond classically mediated antigen- and IgE-induced events. Ann Allergy Asthma Immunol 2017; 118:246.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/9\" class=\"nounderline abstract_t\">Vitte J, Bongrand P. Serum tryptase determination in patients with acute allergic reactions. J Allergy Clin Immunol 2013; 131:1714.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/10\" class=\"nounderline abstract_t\">Finkelman FD, Rothenberg ME, Brandt EB, et al. Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol 2005; 115:449.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/11\" class=\"nounderline abstract_t\">Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113:832.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/12\" class=\"nounderline abstract_t\">Mertes PM, Laxenaire MC, Lienhart A, et al. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol 2005; 15:91.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/13\" class=\"nounderline abstract_t\">Chacko T, Ledford D. Peri-anesthetic anaphylaxis. Immunol Allergy Clin North Am 2007; 27:213.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/14\" class=\"nounderline abstract_t\">Genovese A, Stellato C, Marsella CV, et al. Role of mast cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media. Int Arch Allergy Immunol 1996; 110:13.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/15\" class=\"nounderline abstract_t\">Levy JH, Adkinson NF Jr. Anaphylaxis during cardiac surgery: implications for clinicians. Anesth Analg 2008; 106:392.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/16\" class=\"nounderline abstract_t\">McNeil BD, Pundir P, Meeker S, et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 2015; 519:237.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/17\" class=\"nounderline abstract_t\">Veien M, Szlam F, Holden JT, et al. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells. Anesthesiology 2000; 92:1074.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/18\" class=\"nounderline abstract_t\">Trautmann A, Seidl C, Stoevesandt J, Seitz CS. General anaesthesia-induced anaphylaxis: impact of allergy testing on subsequent anaesthesia. Clin Exp Allergy 2016; 46:125.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/19\" class=\"nounderline abstract_t\">Dong SW, Mertes PM, Petitpain N, et al. Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007). Minerva Anestesiol 2012; 78:868.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/20\" class=\"nounderline abstract_t\">Mertes PM, Demoly P, Malinovsky JM. Hypersensitivity reactions in the anesthesia setting/allergic reactions to anesthetics. Curr Opin Allergy Clin Immunol 2012; 12:361.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/21\" class=\"nounderline abstract_t\">Tacquard C, Collange O, Gomis P, et al. Anaesthetic hypersensitivity reactions in France between 2011 and 2012: the 10th GERAP epidemiologic survey. Acta Anaesthesiol Scand 2017; 61:290.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/22\" class=\"nounderline abstract_t\">Mertes PM, Laxenaire MC, Alla F, Groupe d'Etudes des R&eacute;actions Anaphylacto&iuml;des Peranesth&eacute;siques. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99:536.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/23\" class=\"nounderline abstract_t\">Garvey LH, Roed-Petersen J, Menn&eacute; T, Husum B. Danish Anaesthesia Allergy Centre - preliminary results. Acta Anaesthesiol Scand 2001; 45:1204.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/24\" class=\"nounderline abstract_t\">Meng J, Rotiroti G, Burdett E, Lukawska JJ. Anaphylaxis during general anaesthesia: experience from a drug allergy centre in the UK. Acta Anaesthesiol Scand 2017; 61:281.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/25\" class=\"nounderline abstract_t\">Harboe T, Guttormsen AB, Irgens A, et al. Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology 2005; 102:897.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/26\" class=\"nounderline abstract_t\">Gurrieri C, Weingarten TN, Martin DP, et al. Allergic reactions during anesthesia at a large United States referral center. Anesth Analg 2011; 113:1202.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/27\" class=\"nounderline abstract_t\">Kuhlen JL Jr, Camargo CA Jr, Balekian DS, et al. Antibiotics Are the Most Commonly Identified Cause of Perioperative Hypersensitivity Reactions. J Allergy Clin Immunol Pract 2016; 4:697.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/28\" class=\"nounderline abstract_t\">Mertes PM, Tajima K, Regnier-Kimmoun MA, et al. Perioperative anaphylaxis. Med Clin North Am 2010; 94:761.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/29\" class=\"nounderline abstract_t\">Hwang MJ, Do JY, Choi EW, et al. Immunoglobulin E-mediated hypersensitivity reaction after intraperitoneal administration of vancomycin. Kidney Res Clin Pract 2015; 34:57.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/30\" class=\"nounderline abstract_t\">Minhas JS, Wickner PG, Long AA, et al. Immune-mediated reactions to vancomycin: A systematic case review and analysis. Ann Allergy Asthma Immunol 2016; 116:544.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/31\" class=\"nounderline abstract_t\">Birnbaum J, Porri F, Pradal M, et al. Allergy during anaesthesia. Clin Exp Allergy 1994; 24:915.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/32\" class=\"nounderline abstract_t\">Baldo BA, Fisher MM. Mechanisms in IgE-dependent anaphylaxis to anesthetic drugs. Ann Fr Anesth Reanim 1993; 12:131.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/33\" class=\"nounderline abstract_t\">Koppert W, Blunk JA, Petersen LJ, et al. Different patterns of mast cell activation by muscle relaxants in human skin. Anesthesiology 2001; 95:659.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/34\" class=\"nounderline abstract_t\">Doenicke AW, Czeslick E, Moss J, Hoernecke R. Onset time, endotracheal intubating conditions, and plasma histamine after cisatracurium and vecuronium administration. Anesth Analg 1998; 87:434.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/35\" class=\"nounderline abstract_t\">Baldo BA, Fisher MM. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 1983; 306:262.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/36\" class=\"nounderline abstract_t\">Harboe T, Johansson SG, Florvaag E, Oman H. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy 2007; 62:1445.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/37\" class=\"nounderline abstract_t\">Florvaag E, Johansson SG, Oman H, et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005; 49:437.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/38\" class=\"nounderline abstract_t\">Johansson SG, Florvaag E, Oman H, et al. National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study. Allergy 2010; 65:498.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/39\" class=\"nounderline abstract_t\">Jooste E, Klafter F, Hirshman CA, Emala CW. A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism. Anesthesiology 2003; 98:906.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/40\" class=\"nounderline abstract_t\">Chaiear N, Foulds I, Burge PS. Prevalence and risk factors for latex allergy. Occup Environ Med 2000; 57:501.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/41\" class=\"nounderline abstract_t\">Thong CL, Lambros M, Stewart MG, Kam PC. An unexpected cause of an acute hypersensitivity reaction during recovery from anaesthesia. Anaesth Intensive Care 2005; 33:521.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/42\" class=\"nounderline abstract_t\">Knight BA, Puy R, Douglass J, et al. Chlorhexidine anaphylaxis: a case report and review of the literature. Intern Med J 2001; 31:436.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/43\" class=\"nounderline abstract_t\">Parkes AW, Harper N, Herwadkar A, Pumphrey R. Anaphylaxis to the chlorhexidine component of Instillagel: a case series. Br J Anaesth 2009; 102:65.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/44\" class=\"nounderline abstract_t\">Garvey LH, Kr&oslash;igaard M, Poulsen LK, et al. IgE-mediated allergy to chlorhexidine. J Allergy Clin Immunol 2007; 120:409.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/45\" class=\"nounderline abstract_t\">Krishna MT, York M, Chin T, et al. Multi-centre retrospective analysis of anaphylaxis during general anaesthesia in the United Kingdom: aetiology and diagnostic performance of acute serum tryptase. Clin Exp Immunol 2014; 178:399.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/46\" class=\"nounderline abstract_t\">Weng M, Zhu M, Chen W, Miao C. Life-threatening anaphylactic shock due to chlorhexidine on the central venous catheter: a case series. Int J Clin Exp Med 2014; 7:5930.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/47\" class=\"nounderline abstract_t\">Rutkowski K, Wagner A. Chlorhexidine: a new latex? Eur Urol 2015; 68:345.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/48\" class=\"nounderline abstract_t\">Hong CC, Wang SM, Nather A, et al. Chlorhexidine Anaphylaxis Masquerading as Septic Shock. Int Arch Allergy Immunol 2015; 167:16.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/49\" class=\"nounderline abstract_t\">Sharp G, Green S, Rose M. Chlorhexidine-induced anaphylaxis in surgical patients: a review of the literature. ANZ J Surg 2016; 86:237.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/50\" class=\"nounderline abstract_t\">Zinderman CE, Landow L, Wise RP. Anaphylactoid reactions to Dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004. J Vasc Surg 2006; 43:1004.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/51\" class=\"nounderline abstract_t\">Wiedermann CJ. Hydroxyethyl starch--can the safety problems be ignored? Wien Klin Wochenschr 2004; 116:583.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/52\" class=\"nounderline abstract_t\">Leynadier F, Sansarricq M, Didier JM, Dry J. Prick tests in the diagnosis of anaphylaxis to general anaesthetics. Br J Anaesth 1987; 59:683.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/53\" class=\"nounderline abstract_t\">Fujita A, Kitayama M, Hirota K. Anaphylactoid shock in a patient following 5% human serum albumin infusion during off-pump coronary artery bypass grafting. J Anesth 2007; 21:396.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/54\" class=\"nounderline abstract_t\">Vervloet D, Senft M, Dugue P, et al. Anaphylactic reactions to modified fluid gelatins. J Allergy Clin Immunol 1983; 71:535.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/55\" class=\"nounderline abstract_t\">Russell WJ, Fenwick DG. Anaphylaxis to Haemaccel and cross reactivity to Gelofusin. Anaesth Intensive Care 2002; 30:481.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/56\" class=\"nounderline abstract_t\">Moscicki RA, Sockin SM, Corsello BF, et al. Anaphylaxis during induction of general anesthesia: subsequent evaluation and management. J Allergy Clin Immunol 1990; 86:325.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/57\" class=\"nounderline abstract_t\">Hirshman CA, Edelstein RA, Ebertz JM, Hanifin JM. Thiobarbiturate-induced histamine release in human skin mast cells. Anesthesiology 1985; 63:353.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/58\" class=\"nounderline abstract_t\">Baker MT, Naguib M. Propofol: the challenges of formulation. Anesthesiology 2005; 103:860.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/59\" class=\"nounderline abstract_t\">Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des 2004; 10:3639.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/60\" class=\"nounderline abstract_t\">Wang H, Cork R, Rao A. Development of a new generation of propofol. Curr Opin Anaesthesiol 2007; 20:311.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/61\" class=\"nounderline abstract_t\">Hofer KN, McCarthy MW, Buck ML, Hendrick AE. Possible anaphylaxis after propofol in a child with food allergy. Ann Pharmacother 2003; 37:398.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/62\" class=\"nounderline abstract_t\">Kelso JM. Potential food allergens in medications. J Allergy Clin Immunol 2014; 133:1509.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/63\" class=\"nounderline abstract_t\">Asserh&oslash;j LL, Mosbech H, Kr&oslash;igaard M, Garvey LH. No evidence for contraindications to the use of propofol in adults allergic to egg, soy or peanut&dagger;. Br J Anaesth 2016; 116:77.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/64\" class=\"nounderline abstract_t\">Haybarger E, Young AS, Giovannitti JA Jr. Benzodiazepine Allergy With Anesthesia Administration: A Review of Current Literature. Anesth Prog 2016; 63:160.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/65\" class=\"nounderline abstract_t\">Palacios Benito R, Dom&iacute;nguez Ortega J, Alonso Llamazares A, et al. Adverse reaction to tetrazepam. J Investig Allergol Clin Immunol 2001; 11:130.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/66\" class=\"nounderline abstract_t\">Gooch I, Gwinnutt C. Anaphylaxis to intrathecal diamorphine. Resuscitation 2006; 70:470.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/67\" class=\"nounderline abstract_t\">Bennett MJ, Anderson LK, McMillan JC, et al. Anaphylactic reaction during anaesthesia associated with positive intradermal skin test to fentanyl. Can Anaesth Soc J 1986; 33:75.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/68\" class=\"nounderline abstract_t\">Levy JH, Brister NW, Shearin A, et al. Wheal and flare responses to opioids in humans. Anesthesiology 1989; 70:756.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/69\" class=\"nounderline abstract_t\">Yang WH, Purchase EC, Rivington RN. Positive skin tests and Prausnitz-K&uuml;stner reactions in metabisulfite-sensitive subjects. J Allergy Clin Immunol 1986; 78:443.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/70\" class=\"nounderline abstract_t\">Kendigelen P, BaktirClinic Of Anesthesiology And Reanimation Af&#351;in State Hospital Af&#351;in Kahramanmara&#351; Tureky M, Sucu A, Kaya G. Anaphylaxis after administration of amikacin containing sodium metabisulfite in a premature newborn. Arch Argent Pediatr 2016; 114:e195.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/71\" class=\"nounderline abstract_t\">Cifuentes L, Ring J, Brockow K. Clonal mast cell activation syndrome with anaphylaxis to sulfites. Int Arch Allergy Immunol 2013; 162:94.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/72\" class=\"nounderline abstract_t\">Kounis N, Kounis G. Anaphylactic cardiovascular collapse during anesthesia: the Kounis acute hypersensitivity syndrome seems to be the most likely cause. J Korean Med Sci 2013; 28:638.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/73\" class=\"nounderline abstract_t\">Cochico SG. Propofol allergy: assessing for patient risks. AORN J 2012; 96:398.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/74\" class=\"nounderline abstract_t\">L&oacute;pez S&aacute;ez MP, de Barrio M, Zubeldia JM, et al. Acute IgE-mediated generalized urticaria-angioedema after topical application of povidone-iodine. Allergol Immunopathol (Madr) 1998; 26:23.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/75\" class=\"nounderline abstract_t\">Gray PE, Katelaris CH, Lipson D. Recurrent anaphylaxis caused by topical povidone-iodine (Betadine). J Paediatr Child Health 2013; 49:506.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/76\" class=\"nounderline abstract_t\">Blas M, Briesacher KS, Lobato EB. Bacitracin irrigation: a cause of anaphylaxis in the operating room. Anesth Analg 2000; 91:1027.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/77\" class=\"nounderline abstract_t\">Sprung J, Schedewie HK, Kampine JP. Intraoperative anaphylactic shock after bacitracin irrigation. Anesth Analg 1990; 71:430.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/78\" class=\"nounderline abstract_t\">Damm S. Intraoperative anaphylaxis associated with bacitracin irrigation. Am J Health Syst Pharm 2011; 68:323.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/79\" class=\"nounderline abstract_t\">Sharif S, Goldberg B. Detection of IgE antibodies to bacitracin using a commercially available streptavidin-linked solid phase in a patient with anaphylaxis to triple antibiotic ointment. Ann Allergy Asthma Immunol 2007; 98:563.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/80\" class=\"nounderline abstract_t\">Freiler JF, Steel KE, Hagan LL, et al. Intraoperative anaphylaxis to bacitracin during pacemaker change and laser lead extraction. Ann Allergy Asthma Immunol 2005; 95:389.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/81\" class=\"nounderline abstract_t\">Ebo DG, Bosmans JL, Couttenye MM, Stevens WJ. Haemodialysis-associated anaphylactic and anaphylactoid reactions. Allergy 2006; 61:211.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/82\" class=\"nounderline abstract_t\">Grammer LC, Roberts M, Wiggins CA, et al. A comparison of cutaneous testing and ELISA testing for assessing reactivity to ethylene oxide-human serum albumin in hemodialysis patients with anaphylactic reactions. J Allergy Clin Immunol 1991; 87:674.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/83\" class=\"nounderline abstract_t\">Suzukawa M, Komiya A, Koketsu R, et al. Three cases of ortho-phthalaldehyde-induced anaphylaxis after laryngoscopy: detection of specific IgE in serum. Allergol Int 2007; 56:313.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/84\" class=\"nounderline abstract_t\">Sokol WN. Nine episodes of anaphylaxis following cystoscopy caused by Cidex OPA (ortho-phthalaldehyde) high-level disinfectant in 4 patients after cytoscopy. J Allergy Clin Immunol 2004; 114:392.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/85\" class=\"nounderline abstract_t\">Cooper DE, White AA, Werkema AN, Auge BK. Anaphylaxis following cystoscopy with equipment sterilized with Cidex OPA (ortho-phthalaldehyde): a review of two cases. J Endourol 2008; 22:2181.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/86\" class=\"nounderline abstract_t\">Suzukawa M, Yamaguchi M, Komiya A, et al. Ortho-phthalaldehyde-induced anaphylaxis after laryngoscopy. J Allergy Clin Immunol 2006; 117:1500.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/87\" class=\"nounderline abstract_t\">McGrath KG, Patterson R. Anaphylactic reactivity to streptokinase. JAMA 1984; 252:1314.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/88\" class=\"nounderline abstract_t\">Pechlaner C, Knapp E, Wiedermann CJ. Hypersensitivity reactions associated with recombinant tissue-type plasminogen activator and urokinase. Blood Coagul Fibrinolysis 2001; 12:491.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/89\" class=\"nounderline abstract_t\">Haque RA, Wagner A, Whisken JA, et al. Anaphylaxis to patent blue V: a case series and proposed diagnostic protocol. Allergy 2010; 65:396.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/90\" class=\"nounderline abstract_t\">Scherer K, Studer W, Figueiredo V, Bircher AJ. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol 2006; 96:497.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/91\" class=\"nounderline abstract_t\">Tripathy S, Nair PV. Adverse drug reaction, patent blue V dye and anaesthesia. Indian J Anaesth 2012; 56:563.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/92\" class=\"nounderline abstract_t\">Low AE, McEwan JC, Karanam S, et al. Anaesthesia-associated hypersensitivity reactions: seven years' data from a British bi-specialty clinic. Anaesthesia 2016; 71:76.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/93\" class=\"nounderline abstract_t\">Pinkowski JL, Leeson MC. Anaphylactic shock associated with chymopapain skin test. A case report and review of the literature. Clin Orthop Relat Res 1990; :186.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/94\" class=\"nounderline abstract_t\">Smith MB, Hofmann VC. Anaphylactoid reaction to chymopapain. Anaesthesia 1989; 44:767.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/95\" class=\"nounderline abstract_t\">Nordby EJ, Wright PH, Schofield SR. Safety of chemonucleolysis. Adverse effects reported in the United States, 1982-1991. Clin Orthop Relat Res 1993; :122.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/96\" class=\"nounderline abstract_t\">Moneret-Vautrin DA, Feldmann L, Kanny G, et al. Incidence and risk factors for latent sensitization to chymopapain: predictive skin-prick tests in 700 candidates for chemonucleolysis. Clin Exp Allergy 1994; 24:471.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/97\" class=\"nounderline abstract_t\">Wonders J, Eekhoff EM, Heine R, et al. [Insulin allergy: background, diagnosis and treatment]. Ned Tijdschr Geneeskd 2005; 149:2783.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/98\" class=\"nounderline abstract_t\">Grammer L. Insulin allergy. Clin Rev Allergy 1986; 4:189.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/99\" class=\"nounderline abstract_t\">Phillips JF, Yates AB, Deshazo RD. Approach to patients with suspected hypersensitivity to local anesthetics. Am J Med Sci 2007; 334:190.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/100\" class=\"nounderline abstract_t\">Ring J, Franz R, Brockow K. Anaphylactic reactions to local anesthetics. Chem Immunol Allergy 2010; 95:190.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/101\" class=\"nounderline abstract_t\">Veach SA, Franks AM, Allan MC. Severe anaphylactic reaction after repeated intermittent exposure to lepirudin. Pharmacotherapy 2007; 27:760.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/102\" class=\"nounderline abstract_t\">Bircher AJ, Harr T, Hohenstein L, Tsakiris DA. Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options. Allergy 2006; 61:1432.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/103\" class=\"nounderline abstract_t\">Berkun Y, Haviv YS, Schwartz LB, Shalit M. Heparin-induced recurrent anaphylaxis. Clin Exp Allergy 2004; 34:1916.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/104\" class=\"nounderline abstract_t\">Mozzicato SM, Tripathi A, Posthumus JB, et al. Porcine or bovine valve replacement in 3 patients with IgE antibodies to the mammalian oligosaccharide galactose-alpha-1,3-galactose. J Allergy Clin Immunol Pract 2014; 2:637.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/105\" class=\"nounderline abstract_t\">Uyttebroek A, Sabato V, Bridts CH, et al. Anaphylaxis to succinylated gelatin in a patient with a meat allergy: galactose-&alpha;(1, 3)-galactose (&alpha;-gal) as antigenic determinant. J Clin Anesth 2014; 26:574.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/106\" class=\"nounderline abstract_t\">Khoriaty E, McClain CD, Permaul P, et al. Intraoperative anaphylaxis induced by the gelatin component of thrombin-soaked gelfoam in a pediatric patient. Ann Allergy Asthma Immunol 2012; 108:209.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/107\" class=\"nounderline abstract_t\">Spencer HT, Hsu JT, McDonald DR, Karlin LI. Intraoperative anaphylaxis to gelatin in topical hemostatic agents during anterior spinal fusion: a case report. Spine J 2012; 12:e1.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/108\" class=\"nounderline abstract_t\">Park KW. Protamine and protamine reactions. Int Anesthesiol Clin 2004; 42:135.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/109\" class=\"nounderline abstract_t\">Nybo M, Madsen JS. Serious anaphylactic reactions due to protamine sulfate: a systematic literature review. Basic Clin Pharmacol Toxicol 2008; 103:192.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/110\" class=\"nounderline abstract_t\">Kober BJ, Scheule AM, Voth V, et al. Anaphylactic reaction after systemic application of aprotinin triggered by aprotinin-containing fibrin sealant. Anesth Analg 2008; 107:406.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/111\" class=\"nounderline abstract_t\">Dietrich W, Ebell A, Busley R, Boulesteix AL. Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery. Ann Thorac Surg 2007; 84:1144.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/112\" class=\"nounderline abstract_t\">Ebo DG, Goossens S, Opsomer F, et al. Flow-assisted diagnosis of anaphylaxis to hyaluronidase. Allergy 2005; 60:1333.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/113\" class=\"nounderline abstract_t\">Quhill F, Bowling B, Packard RB. Hyaluronidase allergy after peribulbar anesthesia with orbital inflammation. J Cataract Refract Surg 2004; 30:916.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/114\" class=\"nounderline abstract_t\">Eberhart AH, Weiler CR, Erie JC. Angioedema related to the use of hyaluronidase in cataract surgery. Am J Ophthalmol 2004; 138:142.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/115\" class=\"nounderline abstract_t\">Borchard K, Puy R, Nixon R. Hyaluronidase allergy: a rare cause of periorbital inflammation. Australas J Dermatol 2010; 51:49.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/116\" class=\"nounderline abstract_t\">Delaere L, Zeyen T, Foets B, et al. Allergic reaction to hyaluronidase after retrobulbar anaesthesia: a case series and review. Int Ophthalmol 2009; 29:521.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/117\" class=\"nounderline abstract_t\">Ue KL, Kasternow B, Wagner A, et al. Sugammadex: An emerging trigger of intraoperative anaphylaxis. Ann Allergy Asthma Immunol 2016; 117:714.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/118\" class=\"nounderline abstract_t\">Nakanishi T, Ishida K, Utada K, et al. Anaphylaxis to sugammadex diagnosed by skin prick testing using both sugammadex and a sugammadex-rocuronium mixture. Anaesth Intensive Care 2016; 44:122.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/119\" class=\"nounderline abstract_t\">Baldo BA, McDonnell NJ, Pham NH. Drug-specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy. Clin Exp Allergy 2011; 41:1663.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/120\" class=\"nounderline abstract_t\">Men&eacute;ndez-Ozcoidi L, Ortiz-G&oacute;mez JR, Olaguibel-Ribero JM, Salvador-Bravo MJ. Allergy to low dose sugammadex. Anaesthesia 2011; 66:217.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/121\" class=\"nounderline abstract_t\">Fisher MM, More DG. The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaesth Intensive Care 1981; 9:226.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/122\" class=\"nounderline abstract_t\">Fisher M. Anaphylaxis to anaesthetic drugs. Novartis Found Symp 2004; 257:193.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/123\" class=\"nounderline abstract_t\">Gouel-Ch&eacute;ron A, Neukirch C, Aubier B, et al. Anaphylactic bronchospasm during general anesthesia is not related to asthma. Allergy 2015; 70:453.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/124\" class=\"nounderline abstract_t\">Bridgman DE, Clarke R, Sadleir PH, et al. Systemic mastocytosis presenting as intraoperative anaphylaxis with atypical features: a report of two cases. Anaesth Intensive Care 2013; 41:116.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/125\" class=\"nounderline abstract_t\">Laxenaire MC, Mertes PM, Groupe d'Etudes des R&eacute;actions Anaphylacto&iuml;des Peranesth&eacute;siques. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001; 87:549.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/126\" class=\"nounderline abstract_t\">Jacobsen J, Secher NH. Slowing of the heart during anaphylactic shock. A report of five cases. Acta Anaesthesiol Scand 1988; 32:401.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/127\" class=\"nounderline abstract_t\">Laxenaire MC, Mouton C, Fr&eacute;d&eacute;ric A, et al. [Anaphylactic shock after tourniquet removal in orthopedic surgery]. Ann Fr Anesth Reanim 1996; 15:179.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/128\" class=\"nounderline abstract_t\">Anderson A, Eilers H, Yost CS. Anaphylaxis complicating graft reperfusion during orthotopic liver transplantation: a case report. Transplant Proc 2010; 42:1967.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/129\" class=\"nounderline abstract_t\">Gibbs NM, Sadleir PH, Clarke RC, Platt PR. Survival from perioperative anaphylaxis in Western Australia 2000-2009. Br J Anaesth 2013; 111:589.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/130\" class=\"nounderline abstract_t\">Michalska-Krzanowska G. Tryptase in diagnosing adverse suspected anaphylactic reaction. Adv Clin Exp Med 2012; 21:403.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/131\" class=\"nounderline abstract_t\">Laroche D, Gomis P, Gallimidi E, et al. Diagnostic value of histamine and tryptase concentrations in severe anaphylaxis with shock or cardiac arrest during anesthesia. Anesthesiology 2014; 121:272.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/132\" class=\"nounderline abstract_t\">Borer-Reinhold M, Haeberli G, Bitzenhofer M, et al. An increase in serum tryptase even below 11.4&nbsp;ng/mL may indicate a mast cell-mediated hypersensitivity reaction: a prospective study in Hymenoptera venom allergic patients. Clin Exp Allergy 2011; 41:1777.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/133\" class=\"nounderline abstract_t\">Guyer AC, Saff RR, Conroy M, et al. Comprehensive allergy evaluation is useful in the subsequent care of patients with drug hypersensitivity reactions during anesthesia. J Allergy Clin Immunol Pract 2015; 3:94.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/134\" class=\"nounderline abstract_t\">Sadleir PHM, Clarke RC, Bozic B, Platt PR. Consequences of proceeding with surgery after resuscitation from intra-operative anaphylaxis. Anaesthesia 2018; 73:32.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/135\" class=\"nounderline abstract_t\">Ledford DK. Allergy, anaphylaxis and general anesthesia. Immunology Allergy Clin North Am 2001; 21:795.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/136\" class=\"nounderline abstract_t\">Kannan JA, Bernstein JA. Perioperative anaphylaxis: diagnosis, evaluation, and management. Immunol Allergy Clin North Am 2015; 35:321.</a></li><li><a href=\"https://www.uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management/abstract/137\" class=\"nounderline abstract_t\">Siebenhaar F, Weller K, Mlynek A, et al. Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin Exp Dermatol 2007; 32:241.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2077 Version 19.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H25\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">INCIDENCE</a></li><li><a href=\"#H12436589\" id=\"outline-link-H12436589\">MECHANISMS OF ANAPHYLAXIS</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">ETIOLOGIES</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">More common</a><ul><li><a href=\"#H1262939\" id=\"outline-link-H1262939\">- Antibiotics</a></li><li><a href=\"#H315537455\" id=\"outline-link-H315537455\">- Neuromuscular-blocking agents</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Latex</a></li><li><a href=\"#H118732057\" id=\"outline-link-H118732057\">- Chlorhexidine</a></li></ul></li><li><a href=\"#H597059\" id=\"outline-link-H597059\">Less common</a><ul><li><a href=\"#H1019505258\" id=\"outline-link-H1019505258\">- Colloids and plasma expanders</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">- Hypnotic induction agents</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">- Opioids</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">- Other agents</a></li></ul></li></ul></li><li><a href=\"#H13\" id=\"outline-link-H13\">RISK FACTORS</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">CLINICAL MANIFESTATIONS AND DIAGNOSIS</a><ul><li><a href=\"#H3441557936\" id=\"outline-link-H3441557936\">Characteristic signs and symptoms</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">Timing</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">Severity</a></li></ul></li><li><a href=\"#H3949944398\" id=\"outline-link-H3949944398\">MANAGEMENT</a><ul><li><a href=\"#H2199109078\" id=\"outline-link-H2199109078\">Initial management</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">Laboratory tests at the time of the reaction</a></li><li><a href=\"#H4054093197\" id=\"outline-link-H4054093197\">Decisions regarding proceeding with surgery</a></li></ul></li><li><a href=\"#H20\" id=\"outline-link-H20\">DIFFERENTIAL DIAGNOSIS</a><ul><li><a href=\"#H21\" id=\"outline-link-H21\">Other causes of respiratory or airway symptoms</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">Other causes of hypotension/shock</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">Other causes of angioedema</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">Other causes of urticaria</a></li></ul></li><li><a href=\"#H19132984\" id=\"outline-link-H19132984\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ALLRG/2077|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ALLRG/57346\" class=\"graphic graphic_table\">- Mechanisms of anaphylaxis and pseudoallergic syndromes</a></li><li><a href=\"image.htm?imageKey=ALLRG/60805\" class=\"graphic graphic_table\">- Perioperative anaphylaxis agents and proposed mechanisms</a></li><li><a href=\"image.htm?imageKey=ALLRG/51530\" class=\"graphic graphic_table\">- Articles containing latex</a></li><li><a href=\"image.htm?imageKey=ALLRG/51806\" class=\"graphic graphic_table\">- Perioperative anaphylaxis versus general anaphylaxis</a></li><li><a href=\"image.htm?imageKey=ALLRG/107933\" class=\"graphic graphic_table\">- Anaphylaxis - Perioperative setting (adult)</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=air-embolism\" class=\"medical medical_review\">Air embolism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=allergic-reactions-to-local-anesthetics\" class=\"medical medical_review\">Allergic reactions to local anesthetics</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=allergy-to-meats\" class=\"medical medical_review\">Allergy to meats</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=an-overview-of-angioedema-pathogenesis-and-causes\" class=\"medical medical_review\">An overview of angioedema: Pathogenesis and causes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anaphylaxis-emergency-treatment\" class=\"medical medical_review\">Anaphylaxis: Emergency treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-adult-patients-with-asthma\" class=\"medical medical_review\">Anesthesia for adult patients with asthma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=assessment-of-respiratory-distress-in-the-mechanically-ventilated-patient\" class=\"medical medical_review\">Assessment of respiratory distress in the mechanically ventilated patient</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cardiac-tamponade\" class=\"medical medical_review\">Cardiac tamponade</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cephalosporin-allergy-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Cephalosporin allergy: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-evaluation-and-diagnosis-of-the-nonpregnant-adult-with-suspected-acute-pulmonary-embolism\" class=\"medical medical_review\">Clinical presentation, evaluation, and diagnosis of the nonpregnant adult with suspected acute pulmonary embolism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cold-urticaria\" class=\"medical medical_review\">Cold urticaria</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=fatal-anaphylaxis\" class=\"medical medical_review\">Fatal anaphylaxis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=general-anesthesia-intravenous-induction-agents\" class=\"medical medical_review\">General anesthesia: Intravenous induction agents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hereditary-angioedema-treatment-of-acute-attacks\" class=\"medical medical_review\">Hereditary angioedema: Treatment of acute attacks</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hypersensitivity-reactions-to-insulins\" class=\"medical medical_review\">Hypersensitivity reactions to insulins</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=imaging-of-pneumothorax\" class=\"medical medical_review\">Imaging of pneumothorax</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immediate-hypersensitivity-reactions-to-radiocontrast-media-clinical-manifestations-diagnosis-and-treatment\" class=\"medical medical_review\">Immediate hypersensitivity reactions to radiocontrast media: Clinical manifestations, diagnosis, and treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immediate-hypersensitivity-reactions-to-radiocontrast-media-prevention-of-recurrent-reactions\" class=\"medical medical_review\">Immediate hypersensitivity reactions to radiocontrast media: Prevention of recurrent reactions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immunologic-transfusion-reactions\" class=\"medical medical_review\">Immunologic transfusion reactions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=laboratory-tests-to-support-the-clinical-diagnosis-of-anaphylaxis\" class=\"medical medical_review\">Laboratory tests to support the clinical diagnosis of anaphylaxis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=latex-allergy-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Latex allergy: Epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=latex-allergy-management\" class=\"medical medical_review\">Latex allergy: Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=malignant-hyperthermia-clinical-diagnosis-and-management-of-acute-crisis\" class=\"medical medical_review\">Malignant hyperthermia: Clinical diagnosis and management of acute crisis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mast-cell-disorders-an-overview\" class=\"medical medical_review\">Mast cell disorders: An overview</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nsaids-including-aspirin-allergic-and-pseudoallergic-reactions\" class=\"medical medical_review\">NSAIDs (including aspirin): Allergic and pseudoallergic reactions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neuromuscular-blocking-agents-nmbas-for-rapid-sequence-intubation-in-adults-outside-of-the-operating-room\" class=\"medical medical_review\">Neuromuscular blocking agents (NMBAs) for rapid sequence intubation in adults outside of the operating room</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathophysiology-of-anaphylaxis\" class=\"medical medical_review\">Pathophysiology of anaphylaxis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=penicillin-allergy-immediate-reactions\" class=\"medical medical_review\">Penicillin allergy: Immediate reactions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioperative-anaphylaxis-evaluation-and-prevention-of-recurrent-reactions\" class=\"medical medical_review\">Perioperative anaphylaxis: Evaluation and prevention of recurrent reactions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=respiratory-problems-in-the-post-anesthesia-care-unit-pacu\" class=\"medical medical_review\">Respiratory problems in the post-anesthesia care unit (PACU)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-anaphylaxis\" class=\"medical medical_society_guidelines\">Society guideline links: Anaphylaxis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=systemic-mastocytosis-management-and-prognosis\" class=\"medical medical_review\">Systemic mastocytosis: Management and prognosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=transfusion-related-acute-lung-injury-trali\" class=\"medical medical_review\">Transfusion-related acute lung injury (TRALI)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vancomycin-hypersensitivity\" class=\"medical medical_review\">Vancomycin hypersensitivity</a></li></ul></div></div>","javascript":null}